Showing results (1-10 of 160) with videos related to
Sort By:
Pageof 16
Oncology (Williston Park, N.Y.)|August 25, 2007
Clinical use of monoclonal antibodies to the epidermal growth factor receptor in colorectal cancerBarbara BurtnessExpert Opinion on Biological Therapy|July 30, 2005
The role of cetuximab in the treatment of squamous cell cancer of the head and neckBarbara BurtnessJournal of the National Comprehensive Cancer Network : JNCCN|May 24, 2014
Targeted agents: management of dermatologic toxicitiesBarbara BurtnessJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2015
Human Papillomavirus-Associated Oropharyngeal Cancer: Defining Risk Groups and Clinical TrialsAarti Bhatia, Barbara BurtnessDrugs of Today (Barcelona, Spain : 1998)|April 12, 2005
Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibodyJoanne Harding, Barbara BurtnessDrugs|January 16, 2023
Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 UpdateAarti Bhatia, Barbara BurtnessCancers|September 1, 2017
Novel Molecular Targets for Chemoprevention in Malignancies of the Head and NeckAarti Bhatia, Barbara BurtnessExpert Opinion on Biological Therapy|August 22, 2006
Antibody therapy for early-stage breast cancer: trastuzumab adjuvant and neoadjuvant trialsRanee Mehra, Barbara BurtnessPageof 16